北京大学学报(医学版) ›› 2020, Vol. 52 ›› Issue (6): 995-1000. doi: 10.19723/j.issn.1671-167X.2020.06.002
朱冯赟智1,邢晓燕2,汤晓菲3,李依敏1,邵苗1,张学武1,李玉慧1,△(),孙晓麟1,何菁1
Feng-yun-zhi ZHU1,Xiao-yan XING2,Xiao-fei TANG3,Yi-min LI1,Miao SHAO1,Xue-Wu ZHANG1,Yu-hui LI1,△(),Xiao-lin SUN1,Jing HE1
摘要:
目的:探讨合并血栓栓塞的肌炎患者的临床及免疫学特征。方法:回顾性分析2003—2019年于北京大学人民医院住院的390例肌炎患者的病历资料,包括人口学特征、皮肤、肌肉表现、脏器受累、实验室指标(肌酶、白蛋白、凝血功能、炎性指标、肌炎特异性/相关性抗体)、治疗方案,并根据有无合并血栓栓塞将患者进行分组比较,应用Logistic回归分析明确肌炎合并血栓栓塞的危险因素。结果:肌炎患者平均起病年龄(49.6±13.4)岁,男女比例为0.31:1,血栓栓塞发生率为4.62%(18/390),其中,55.6%(10/18)为下肢深静脉血栓形成,其次为脑梗塞(22.2%,4/18)、肺栓塞(11.1%,2/18)、肾动脉栓塞(5.6%,1/18)、上肢静脉血栓形成(5.6 %,1/18)。血栓栓塞发生时间方面,38.9%(7/18)发生在肌炎诊断的前后6个月内,50%(9/18)发生在肌炎确诊后。合并血栓栓塞的肌炎患者起病年龄偏大,平均(58.3±11.7)岁,合并糖尿病(44.4% vs. 16.4%,P=0.006)、冠心病(22.2% vs. 3.0%,P=0.003)、 90 d内手术史(16.7% vs. 3.5%,P=0.032)等并发症均高于无血栓栓塞组。实验室检查方面,合并血栓栓塞的肌炎患者C-反应蛋白(12.2 mg/L vs. 4.1 mg/L,P<0.001)、血清铁蛋白(20 085.5 μg/L vs. 216.6 μg/L,P<0.001)、血清白蛋白水平(32.4 g/L vs. 36.5 g/L,P=0.002)、D-二聚体(529.0 μg/L vs. 268.0 μg/L,P=0.002)均明显升高,活化部分凝血酶原时间(26.9 s vs. 28.7 s,P=0.049)显著低于无血栓栓塞组。肌炎发生血栓栓塞的危险因素包括:白蛋白水平降低(OR=0.831,95%CI:0.736~0.939,P=0.003)、合并糖尿病(OR=4.468,95%CI:1.382~14.448,P=0.012)、合并冠心病(OR=22.079,95%CI:3.589~135.837,P=0.001)。未见肌炎特异性抗体与血栓栓塞发生的相关性。结论:肌炎患者可发生血栓栓塞事件,合并白蛋白水平降低、糖尿病、冠心病的肌炎患者发生血栓栓塞的风险高,临床应高度警惕。
中图分类号:
[1] |
Lundberg IE, Tjärnlund A, Bottai M, et al. 2017 European League Against Rheumatism/American College of rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups[J]. Arthritis Rheumatol, 2017,69(12):2271-2282.
doi: 10.1002/art.40320 pmid: 29106061 |
[2] |
Ogdie A, Kay McGill N, Shin DB, et al. Risk of venous thromboembolism in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: A general population-based cohort study[J]. Eur Heart J, 2018,39(39):3608-3614.
doi: 10.1093/eurheartj/ehx145 pmid: 28444172 |
[3] |
Aviña-Zubieta JA, Vostretsova K, De Vera MA, et al. The risk of pulmonary embolism and deep venous thrombosis in systemic lupus erythematosus: A general population-based study[J]. Semin Arthritis Rheum, 2015,45(2):195-201.
doi: 10.1016/j.semarthrit.2015.05.008 pmid: 26364556 |
[4] |
Carruthers EC, Choi HK, Sayre EC, et al. Risk of deep venous thrombosis and pulmonary embolism in individuals with polymyositis and dermatomyositis: A general population-based study[J]. Ann Rheum Dis, 2016,75(1):110-116.
doi: 10.1136/annrheumdis-2014-205800 pmid: 25193998 |
[5] | Antovic A, Notarnicola A, Svensson J, et al. Venous thromboembolic events in idiopathic inflammatory myopathy: Occurrence and relation to disease onset[J]. Arthritis Care Res (Hoboken), 2018,70(12):1849-1855. |
[6] | Bohan A, Peter J B. Polymyositis and dermatomyositis (first of two parts)[J]. N Engl J Med, 1975,292(7):403-407. |
[7] |
Sontheimer RD. Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis siné myositis) as a distinctive subset within the idiopathic inflammatory dermatomyo-pathies spectrum of clinical illness?[J]. J Am Acad Dermatol, 2002,46(4):626-636.
pmid: 11907524 |
[8] |
Smith SC Jr, Allen J, Blair SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute[J]. Circulation, 2006,113(19):2363-2372.
pmid: 16702489 |
[9] |
Heit JA, Spencer FA, White RH. The epidemiology of venous thromboembolism[J]. J Thromb Thrombolysis, 2016,41(1):3-14.
pmid: 26780736 |
[10] |
Holmqvist M, Ljung L, Askling J. Acute coronary syndrome in new-onset rheumatoid arthritis: A population-based nationwide cohort study of time trends in risks and excess risks[J]. Ann Rheum Dis, 2017,76(10):1642-1647.
doi: 10.1136/annrheumdis-2016-211066 pmid: 28710095 |
[11] | Schoenfeld SR, Choi HK, Sayre EC, et al. Risk of pulmonary embolism and deep venous thrombosis in systemic sclerosis: A general population-based study[J]. Arthritis Care Res (Hoboken), 2016,68(2):246-253. |
[12] | Zöller B, Li X, Sundquist J, et al. Risk of pulmonary embolism in patients with autoimmune disorders: A nationwide follow-up study from Sweden[J]. Lancet, 2012,379(9812):244-249. |
[13] |
Xu J, Lupu F, Esmon CT. Inflammation, innate immunity and blood coagulation[J]. Hamostaseologie, 2010,30(1):5-9.
pmid: 20162248 |
[14] |
Choi HK, Rho YH, Zhu Y, et al. The risk of pulmonary embo-lism and deep vein thrombosis in rheumatoid arthritis: A UK population-based outpatient cohort study[J]. Ann Rheum Dis, 2013,72(7):1182-1187.
pmid: 22930596 |
[15] |
Saghazadeh A, Rezaei N. Inflammation as a cause of venous thromboembolism[J]. Crit Rev Oncol Hematol, 2016,99:272-285.
doi: 10.1016/j.critrevonc.2016.01.007 pmid: 26811138 |
[16] | Mussbacher M, Salzmann M, Brostjan C, et al. Cell type-specific roles of NF-κB linking inflammation and thrombosis [J/OL]. Front Immunol, (2019-02-04)[2020-04-30]. doi: 10.3389/fimmu.2019.00085. |
[17] | Ramagopalan SV, Wotton CJ, Handel AE, et al. Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: Record-linkage study [J/OL]. BMC Med, (2011-01-10)[2020-04-30]. doi: 10.1186/1741-7015-9-1. |
[1] | 肖云抒,朱冯赟智,罗澜,邢晓燕,李玉慧,张学武,沈丹华. 88例重叠肌炎的临床及免疫学特征[J]. 北京大学学报(医学版), 2021, 53(6): 1088-1093. |
[2] | 罗澜,邢晓燕,肖云抒,陈珂彦,朱冯赟智,张学武,李玉慧. 抗合成酶综合征合并心脏受累患者的临床及免疫学特征[J]. 北京大学学报(医学版), 2021, 53(6): 1078-1082. |
[3] | 张朴丽,杨红霞,张立宁,葛勇鹏,彭清林,王国春,卢昕. 血清YKL-40在诊断抗黑色素瘤分化相关基因5阳性皮肌炎合并严重肺损伤中的价值[J]. 北京大学学报(医学版), 2021, 53(6): 1055-1060. |
[4] | 伊文霞,魏翠洁,吴晔,包新华,熊晖,常杏芝. 长疗程利妥昔单抗治疗难治性幼年型特发性炎症性肌病3例[J]. 北京大学学报(医学版), 2021, 53(6): 1191-1195. |
[5] | 吴燕芳,高飞,林滇恬,陈志涵,林禾. 托法替布联合治疗抗MDA5抗体阳性的无肌病皮肌炎并发快速进展型间质性肺病5例临床分析[J]. 北京大学学报(医学版), 2021, 53(5): 1012-1016. |
[6] | 郑艺明,郝洪军,刘怡琳,郭晶,赵亚雯,张巍,袁云. Ro52抗体与其他肌炎抗体共阳性的相关性研究[J]. 北京大学学报(医学版), 2020, 52(6): 1088-1092. |
[7] | 甘雨舟,李玉慧,张丽华,马琳,何文雯,金月波,安媛,栗占国,叶华. 临床无肌病性皮肌炎与皮肌炎临床及免疫学特征比较[J]. 北京大学学报(医学版), 2020, 52(6): 1001-1008. |
[8] | 赵静,孙峰,李云,赵晓珍,徐丹,李英妮,李玉慧,孙晓麟. 抗α-1C微管蛋白抗体在系统性硬化症中的表达及临床意义[J]. 北京大学学报(医学版), 2020, 52(6): 1009-1013. |
[9] | 杨红霞,田小兰,江薇,李文丽,刘青艳,彭清林,王国春,卢昕. 免疫介导坏死性肌病的临床和病理特征分析[J]. 北京大学学报(医学版), 2019, 51(6): 989-995. |
[10] | 李英妮,相晓红,赵静,李云,孙峰,王红彦,贾汝琳,胡凡磊. 抗类瓜氨酸化抗体在系统性红斑狼疮中的意义[J]. 北京大学学报(医学版), 2019, 51(6): 1019-1024. |
[11] | 徐婧,徐静,李鹤,唐杰,舒建龙,张婧,石连杰,李胜光. 皮肌炎合并IgA血管炎1例[J]. 北京大学学报(医学版), 2019, 51(6): 1173-1177. |
[12] | 张志刚,刘新民. 急性肾梗死的临床特征:单中心52例临床分析[J]. 北京大学学报(医学版), 2019, 51(5): 863-869. |
[13] | 张玮,张培训. 老年髋部骨折患者围手术期血栓预防时限分析[J]. 北京大学学报(医学版), 2019, 51(3): 501-504. |
[14] | 杨伊莹,左晓霞,朱红林,刘思佳. 皮肌炎/多肌炎表观遗传学标志物的研究进展[J]. 北京大学学报(医学版), 2019, 51(2): 374-377. |
[15] | 王永福,刘媛. 自身抗体在肿瘤及感染性疾病发生、发展中的作用[J]. 北京大学学报(医学版), 2018, 50(6): 952-955. |
|